New FDA Approved Light Therapy for Macular Degeneration Raises Questions

Experts Debate Whether the Valeda Light Delivery System Was Approved Too Soon

Topline

A novel light therapy device for dry age-related macular degeneration (AMD) has been approved, but experts warn that critical questions about its efficacy and safety remain. While the LIGHTSITE III trial demonstrated modest improvements in visual acuity, concerns about small sample size, treatment burden, and long-term effects suggest the need fo…